TD Cowen Raises Price Targets on Coca-Cola, HCA, Chubb and Beta Bionics
TD Cowen lifted its price targets to $104 for Coca-Cola, $486 for HCA Healthcare, $379 for Chubb and $21 for Beta Bionics, per Dow Jones Newswires.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Dow Jones Newswires reports that TD Cowen has raised its price targets on four companies listed in the US. Its target on Coca-Cola (KO) rose to $104.00 per share from $100.00, and the firm kept its Buy rating. For HCA Healthcare, the target moved up to $486.00 from $460.00.
The brokerage also raised its target on Chubb Ltd to $379.00 from $360.00, and on Beta Bionics (BBNX) to $21.00 from $18.00. The updates were published on October 28, 2026, between 16:41 and 16:56 GMT.
why it matters
Analyst price target changes are a routine event. They reflect a brokerage's updated valuation rather than new company data. Such moves rarely affect the broader market, and interest in them is usually limited to the stocks and their coverage.
tags
instruments
sources
- Coca-Cola Price Target Raised to $104.00/Share From $100.00 by TD Cowen — Dow Jones Newswires, 28 October 2026 at 16:41 UTC
- HCA Healthcare Price Target Raised to $486.00/Share From $460.00 by TD Cowen — Dow Jones Newswires, 28 October 2026 at 16:56 UTC
- Chubb Ltd Price Target Raised to $379.00/Share From $360.00 by TD Cowen — Dow Jones Newswires, 28 October 2026 at 16:54 UTC
- Beta Bionics Price Target Raised to $21.00/Share From $18.00 by TD Cowen — Dow Jones Newswires, 28 October 2026 at 16:52 UTC
- NXP Semiconductors Price Target Raised to $280.00/Share From $275.00 by TD Cowen — Dow Jones Newswires, 28 October 2026 at 17:01 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗